Article
Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infection
2022-04-06
Abstract excerpt
Tuberculosis remains one of the leading causes of death from a single infectious agent, surpassing both AIDS and malaria. In recent years, two bicyclic nitroimidazole drugs, delamanid and pretomanid have been approved to treat this airborne infection. This has spurred a renewed interest in developing new and improved nitroimidazole analogs. We have previously identified a new bicyclic heteroaromatic subclass, the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5edac48d-abe1-507c-bf50-c52417d4fe41
- DOI
- 10.1101/2022.04.05.487095
